Voices
Aditya Dhanawat
Aditya Dhanawat/X

Aditya Dhanawat: A Safe Option for Stage I Seminoma

Aditya Dhanawat, Assistant Professor (Medical Oncology) at Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), shared a post on X:

“Long-term outcomes from India support active surveillance as a safe option for stage I seminoma in a resource-constrained setting!”

Title: Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinent

Authors: Aditya Dhanawat, Debdeep Samaddar, Bhagyashri Jadhav, Atul Tiwari, Kunal Jobanputra, Arnav Tongaonkar, Minit Jalan Shah, Nandini Menon, Priyamvada Maitre, Mahendra Pal, Amandeep Arora, Aparna Ringe, Archi Agrawal, Santosh Menon, Gagan Prakash, Vedang Murthy, Vanita Noronha, Kumar Prabhash, Amit Joshi

Read The Full Article at ecancer.

Aditya Dhanawat: A Safe Option for Stage I Seminoma

More Posts Featuring Seminoma.

Aditya Dhanawat Amandeep Arora Amit Joshi Aparna Ringe Archi Agrawal Arnav Tongaonkar Atul Tiwari Bhagyashri Jadhav cancer Debdeep Samaddar Gagan Prakash Kumar Prabhash Kunal Jobanputra Mahendra Pal Minit Jalan Shah Nandini Menon OncoDaily Oncology Priyamvada Maitre Santosh Menon seminoma Vanita Noronha Vedang Murthy